Abstract: |
Using a modified alkaline-phosphatase/antialkaline-phosphatase method for phenotyping fresh human leukemias, we could demonstrate peripheral blood and bone marrow-derived blast cells to specifically react with two monoclonal antibodies (MoAbs), H25 and H366, previously shown to recognize natural killer cells, activated T lymphocytes and a proportion of normal hematopoietic precursor cells. MoAbs H25 and H366 were found to identify the majority of leukemic cells in patients presenting with T-ALL, LGL leukemia, pre-B-ALL, CML, and AML, respectively. © 1989 S. Karger AG, Basel. |
Keywords: |
leukemia; major clinical study; phenotype; animal; mice; mice, inbred balb c; monoclonal antibody; alkaline phosphatase; antibodies, monoclonal; antigens, neoplasm; immunocytochemistry; cell surface marker; natural killer cell; killer cells, natural; cytochemistry; antigens, surface; natural killer cells; leukemia, myelocytic, acute; leukemia, t-cell, acute; leukemia, myeloid, chronic; leukemia, lymphocytic; leukemia, hairy cell; human; male; female; priority journal; cell surface antigens; antialkaline phosphatase
|